Jessica Burkeen
Acute Care · Huntsville, ALNPI 1306346150
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 358 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,729, more than ten times the $220 reported in 2021. Among acute care clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$852
- Sanofi$645
- Harmony Biosciences LLC$504
- Regeneron Healthcare Solutions, Inc.$489
- Boehringer Ingelheim$479
- plus $3K from 25 others
What the payments were for
- Food & beverage$7,699100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 81 | $1,291 |
| AstraZeneca | 30 | $852 |
| Sanofi | 26 | $645 |
| Harmony Biosciences LLC | 18 | $504 |
| Regeneron Healthcare Solutions, Inc. | 19 | $489 |
| Boehringer Ingelheim | 21 | $479 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $472 |
| Insmed, Inc. | 19 | $461 |
| Grifols USA, LLC | 16 | $401 |
| Jazz Pharmaceuticals Inc. | 12 | $319 |
| Axsome Therapeutics, Inc. | 17 | $275 |
| Mylan Specialty L.p. | 11 | $227 |
| Pfizer | 13 | $211 |
| Viatris Specialty LLC | 5 | $118 |
| Amgen | 5 | $108 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $99 |
| Actelion Pharmaceuticals US, Inc. | 5 | $91 |
| Genentech USA, Inc. | 5 | $89 |
| Verona Pharma, Inc. | 4 | $89 |
| Inogen, Inc. | 4 | $70 |
| Inspire Medical Systems, Inc. | 2 | $59 |
| Philips North America LLC | 3 | $57 |
| Merck | 4 | $57 |
| Baxter Healthcare | 3 | $50 |
| United Therapeutics Corporation | 2 | $41 |
| Melinta Therapeutics, LLC | 2 | $37 |
| CSL Behring | 1 | $35 |
| Optinose US, Inc. | 1 | $19 |
| Pulmonx Corporation | 1 | $19 |
| Gilead | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,699 in reported general payments places this provider in the 90th percentile of 711 acute care providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 20 | $7,518 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 14 | $5,813 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,933 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 61 | $1,384 |
| Pantoprazole Sodium | 12 | $107 |
| Prednisone | 33 | $104 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta | $1,291 | $7,51820 claims |
| Boehringer IngelheimStiolto Respimat | $479 | $5,81314 claims |
| AstraZenecaSymbicort | $852 | $2,93311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 711 acute care providers in Alabama.
Other acute care in Huntsville
- April KlarHuntsville$13K
- Stephanie TateHuntsville$13K
- Kelly VazquezHuntsville$12K
- Summer SlaterHuntsville$12K
- Tiffany RentzHuntsville$11K
- Britanie MooreHuntsville$9K
- Trey WilsonHuntsville$8K
- Esther HambrickHuntsville$8K
- Alyssa EzellHuntsville$8K
- Ashley WrightHuntsville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.